Zhejiang Medicine Co., Ltd. (SHA:600216)

Zhejiang Medicine Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,603	15,252	10,281	11,203	16,368	13,033
Market Cap Growth	-8.50%	48.35%	-8.23%	-31.56%	25.59%	1.87%
Enterprise Value	11,524	14,305	9,752	10,751	15,886	12,611
Last Close Price	14.35	15.48	10.33	11.09	15.83	12.43
PE Ratio	11.06	13.14	23.93	20.76	15.66	18.17
Forward PE	13.29	10.55	13.58	15.18	12.31	8.94
PS Ratio	1.52	1.63	1.32	1.38	1.79	1.78
PB Ratio	1.21	1.40	1.03	1.15	1.78	1.62
P/TBV Ratio	1.30	1.53	1.16	1.32	2.04	1.79
P/FCF Ratio	8.97	28.55	-	-	83.06	18.07
P/OCF Ratio	6.73	12.47	16.21	21.52	14.40	10.37
EV/Sales Ratio	1.29	1.53	1.25	1.33	1.74	1.72
EV/EBITDA Ratio	6.33	7.52	13.81	9.19	9.09	9.84
EV/EBIT Ratio	9.49	11.46	-	21.95	13.69	16.22
EV/FCF Ratio	7.60	26.78	-	-	80.62	17.48
Debt / Equity Ratio	0.09	0.07	0.08	0.09	0.05	0.12
Debt / EBITDA Ratio	0.52	0.40	1.15	0.71	0.27	0.74
Debt / FCF Ratio	0.63	1.42	-	-	2.42	1.32
Asset Turnover	0.65	0.71	0.62	0.65	0.79	0.70
Inventory Turnover	2.81	2.70	2.69	2.81	3.30	3.03
Quick Ratio	1.95	1.67	1.39	1.40	1.30	1.82
Current Ratio	2.79	2.56	2.26	2.29	2.00	2.66
Return on Equity (ROE)	10.34%	9.79%	2.81%	3.84%	10.28%	8.10%
Return on Assets (ROA)	5.50%	5.87%	-0.09%	2.45%	6.30%	4.66%
Return on Invested Capital (ROIC)	11.25%	11.43%	-0.16%	4.49%	12.30%	8.50%
Return on Capital Employed (ROCE)	10.50%	11.10%	-0.20%	4.90%	12.20%	9.10%
Earnings Yield	9.15%	7.61%	4.18%	4.82%	6.39%	5.50%
FCF Yield	11.15%	3.50%	-1.58%	-4.06%	1.20%	5.54%
Dividend Yield	2.48%	2.39%	1.45%	1.53%	2.08%	1.85%
Payout Ratio	30.15%	14.67%	44.67%	65.07%	24.88%	140.26%
Buyback Yield / Dilution	-0.96%	-0.72%	0.91%	-0.47%	-0.26%	-0.46%
Total Shareholder Return	1.51%	1.67%	2.36%	1.06%	1.83%	1.39%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.